Unusual Machines - UMAC STOCK NEWS

Calidi Biotherapeutics (NYSE American: CLDI) and Unusual Machines (NYSE American: UMAC) will feature on the RedChip Small Stocks, Big Money™ show on Bloomberg TV, airing on May 18 at 7 p.m. ET.

Calidi Biotherapeutics, led by CEO Allan Camaisa, specializes in oncolytic virotherapy (OV) for cancer treatment. Their engineered viruses target cancer cells and bolster the immune system, showing promising initial study results. Calidi's unique technologies enhance OV efficacy and treatment potential.

Unusual Machines, headed by CEO Allan Evans, focuses on the drone industry. The company is growing through strategic acquisitions and development of FPV products, aiming to serve various industries like consumer, public safety, and drone delivery. Subsidiaries Fat Shark and Rotor Riot lead in FPV experiences, positioning the company for long-term success.

Unusual Machines (NYSE American: UMAC) issued a shareholder letter detailing its post-IPO achievements and strategic initiatives. The company raised $5 million in its IPO and acquired Rotor Riot and Fat Shark, generating $619,000 in sales within 45 days and achieving over 30% gross margins. Despite a net loss of $1.1 million due to integration costs, Unusual Machines ended Q1 with $3.2 million in cash. The company plans to expand into the defense sector, developing NDAA-compliant drone components. Future focus areas include leveraging Rotor Riot's e-commerce growth and securing Blue UAS certifications.

Unusual Machines (NYSE American: UMAC), a drone and drone components manufacturer, will host a webcast on May 15, 2024, at 4:30 p.m. ET to discuss its Q1 2024 financial results. The event will cover the Company's operational and financial highlights for the first quarter ending March 31, 2024. The webcast will feature prepared remarks from management followed by a Q&A session. For those unable to attend, a replay will be available for six months on the investor relations section of the Company's website.

Unusual Machines, Inc. (NYSE American: UMAC) has formalized the CEO's contract for two years, showcasing rapid business development. Under Allan Evans' leadership, the company successfully listed on NYSE American, acquired Rotor Riot and Fat Shark, reincorporated in Nevada, and joined the Red Cat Futures Initiative. The company is focused on U.S.-based drone component production and plans to release a U.S.-made flight controller for FPV drones in Q2 2024, aiming for Blue UAS certification. The leadership team's strategic vision and operational transformations are driving growth and innovation within the company.

Enlivex Therapeutics and Unusual Machines Inc. will be featured on the RedChip Small Stocks, Big Money™ show on Bloomberg TV. Enlivex Therapeutics, led by CEO Oren Hershkovitz, offers a promising investment opportunity in the biopharmaceutical sector with its innovative Allocetra™ cell therapy platform. The technology aims to reset immune cells for treating inflammatory and autoimmune diseases. On the other hand, Unusual Machines, under CEO Allan Evans, is focusing on the drone industry, acquiring valuable IP and brands to cater to various sectors. The company's subsidiaries, Fat Shark and Rotor Riot, are leading in FPV products and services, positioning Unusual Machines for long-term growth.

Unusual Machines, Inc. appoints FPV drone expert Drew Camden as Chief Operating Officer, highlighting his successful leadership at Rotor Riot and significant revenue growth. Camden's diverse experience and proven track record position him to drive Unusual Machines' expansion in the drone industry.

Unusual Machines, Inc. (UMAC) has completed the acquisitions of Fat Shark Holdings, Ltd. and Rotor Riot LLC, positioning itself in the FPV drone market. The integration is expected to strengthen the company's market position, with historical revenues of the acquired companies showing a 26.1% increase year-over-year. Unusual Machines aims to expand its customer base, invest in new products and intellectual property, and pursue further acquisitions to enhance its offerings.

Unusual Machines, Inc. closes IPO, offering 1,250,000 shares of common stock at $4.00 per share, trading on NYSE American under the ticker symbol 'UMAC'. The company expects $5.0 million in gross proceeds. Underwriters granted a 45-day option for additional shares. Legal counsel and registration details provided for the Offering.

Dominari Holdings Inc. facilitated Unusual Machines' IPO on NYSE American, raising $5.0 million through the sale of 1,250,000 shares at $4.00 per share. Unusual Machines, a FPV drone technology company, commenced trading on February 14, 2024, under the ticker symbol 'UMAC'.